Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Kurume Medical Journal|July 5, 2017
A Rare Case of Ulcerative Colitis with Neurofibromatosis Type 1Shuhei Fukunaga, Hidetoshi Takedatsu, Keiichi Mitsuyama, et al.
World Journal of Gastroenterology|January 27, 2016
Antibody markers in the diagnosis of inflammatory bowel diseaseKeiichi Mitsuyama, Mikio Niwa, Hidetoshi Takedatsu, et al.
Inflammatory Bowel Diseases|December 11, 2019
Leukocyte Apheresis Using a Fiber Filter Suppresses Colonic Injury Through Calcitonin Gene-Related Peptide InductionHiroshi Yamasaki, Keiichi Mitsuyama, Shinichiro Yoshioka, et al.
Medicina (Kaunas, Lithuania)|August 26, 2022
Effect of Direct-Acting Antiviral Agents on Gastroesophageal Varices in Patients with Hepatitis C Virus-Related CirrhosisHiroshi Hisanaga, Hidetoshi Takedatsu, Keigo Emori, et al.
Journal of Gastroenterology and Hepatology|March 8, 2018
Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel diseaseHidetoshi Takedatsu, Keiichi Mitsuyama, Shuhei Fukunaga, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Metabolic dysfunction-associated steatotic liver disease is a risk factor for gallstones: A multicenter cohort studyTomonori Cho, Shuhei Fukunaga, Daiki Ohzono, et al.
Cytotherapy|December 25, 2015
A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapyKotaro Kuwaki, Keiichi Mitsuyama, Hayato Kaida, et al.
Molecular Medicine Reports|July 20, 2016
Increased levels of circulating adrenomedullin following treatment with TU‑100 in patients with Crohn's diseaseKen Kominato, Hiroshi Yamasaki, Keiichi Mitsuyama, et al.
International Journal of Molecular Medicine|November 9, 2017
Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localizationShuhei Fukunaga, Kotaro Kuwaki, Keiichi Mitsuyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2022
Lean/normal-weight metabolic dysfunction-associated fatty liver disease is a risk factor for reflux esophagitisShuhei Fukunaga, Dan Nakano, Tsubasa Tsutsumi, et al.
Pageof 3